Scroll
To Top

Von Hippel Lindau Disease - Video

The animated videos in NORD’s Rare Disease Video Library provide brief introductions to rare disease topics for patients, caregivers, students, professionals and the public. NORD collaborates with medical experts, patient organizations, videographers and Osmosis to develop the videos, which are made possible by individual donations, educational grants and corporate sponsorships. NORD is solely responsible for the content.


General Discussion

Summary

VHL or von Hippel-Lindau disease is an autosomal dominant genetic condition resulting from a deletion or mutation in the VHL gene. VHL disease effects 1 in 36,000 people (10,000 cases in the U.S and 200,000 cases worldwide) and 20% of patients are first-in-family or de novo cases. The mean age of onset of 26 years and 97% of people with a VHL gene mutation have symptoms by the age of 65. VHL disease affects males and females and all ethnic groups equally, and occurs in all parts of the world.
People who have VHL disease may experience tumors and/or cysts in up to ten parts of the body, including the brain, spine, eyes, kidneys, pancreas, adrenal glands, inner ears, reproductive tract, liver and lung:

  • Brain/Spinal Hemangioblastoma
    Headaches, ataxia, nystagmus, back pain, numbness, hiccups
  • Retinal Hemangioblastoma
    Floaters, retinal detachment
  • Endolymphatic Sac Tumor
    Hearing loss, tinnitus, vertigo
  • Pancreatic Cysts/Tumor/Cancer
    Pancreatitis (from blockage of bile ducts), diabetes (from blockage of insulin
    delivery), digestion irritability, malabsorption, jaundice
  • Pheochromocytoma, Paraganglioma
    High blood pressure, panic attacks (or post-operative adrenal insufficiency)
  • Kidney Cysts, Renal Cell Carcinoma
    Lower back pain, hematuria, fatigue
  • Cystadenomas (males and females)
    Pain: consider rupture, hemorrhage, torsion (possible ovarian cancer)

Most of these VHL tumors are benign, but that does not mean they are problem-free. In fact, benign VHL tumors can still be very serious. As they grow in size, these tumors and the associated cysts can cause an increased pressure on the structure around them. This pressure can create symptoms including severe pain or worse.

VHL disease is different in every patient, even within the same family. Since it is impossible to predict exactly how and when the disease will present for each person, it is very important to check regularly for possible VHL manifestations throughout a person’s lifetime.

Currently, a drug (pharmacological) treatment is not available; surgical removal is the method of treatment. An organ sparing approach is the best approach for reducing irreparable damage while minimalizing the need for organ removal. For this reason, Active Surveillance Guidelines were developed to make sure VHL tumors can be found and managed appropriately. With careful monitoring, early detection, and appropriate treatment, the most harmful consequences of this gene mutation can be greatly reduced, or in some people, completely prevented.

Introduction

Because VHL disease can cause malignant tumors, it is considered one of a group of familial cancer risk factors, which are transmitted genetically. The objective is to find tumors early, watch for signs that a tumor is growing, and remove or disable the tumor before it invades other tissues. Benign tumors may also need treatment or removal if their growth causes symptoms.

Synonyms of Von Hippel Lindau Disease

  • VHL
  • VHL syndrome
  • VHL disease
  • von Hippel-Lindau syndrome

Read full report about Von Hippel-Lindau Disease >